贵州省委贵州省12.pptVIP

  • 3
  • 0
  • 约8.13千字
  • 约 36页
  • 2020-08-06 发布于湖北
  • 举报
Adventitious Agent Testing of Novel Cell Substrates for Vaccine Manufacture Arifa S. Khan, PhD. Division of Viral Products Office of Vaccines Research and Review CBER, FDA November 16, 2005;Outline Cell substrates used in U.S. licensed viral vaccines Safety concerns and challenges for testing novel cell substrates, especially tumorigenic cells FDA experience with tumorigenic cell substrates Testing recommendations for novel and tumorigenic cell substrates, such as Madin-Darby canine kidney (MDCK) cells;Types of Cell Substrates Used in Current U.S. Licensed Viral Vaccines;U.S. Licensed Viral

文档评论(0)

1亿VIP精品文档

相关文档